poisar

Stock

Oculis Holding AG OCS

$12.91+0.70%

Overview

OCS market data

Price History

OCS price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.89
Diluted earnings per share over the trailing twelve months.
Beta
0.26
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$10.52 – $34.48
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $732.9M · P/B 4.73.

Company News

10 captured
JP Morgan Maintains Overweight on Oculis Holding, Lowers Price Target to $20Benzinga · Aug 14, 2026, 4:25 PM
Oculis Acquires Accure's Privosegtor And ACT-02 Assets In Deal Worth $3.8M Upfront Cash And Up To 2,050,000 SharesBenzinga · Aug 10, 2026, 7:37 AM
Oculis Holding Q2 EPS $(0.20) Beats $(0.48) Estimate, Sales $392.150K Beat $260.000K EstimateBenzinga · Aug 7, 2026, 7:54 AM
HC Wainwright & Co. Maintains Buy on Oculis Holding, Maintains $26 Price TargetBenzinga · Aug 5, 2026, 11:11 AM
Oculis To Submit IND For Privosegtor In Acute MS Relapses In Q4 2026, Backed By Positive FDA Pre-IND Guidance And Prior Optic Neuritis DataBenzinga · Aug 3, 2026, 8:01 AM
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market SessionBenzinga · Jul 17, 2026, 12:02 PM
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026Globenewswire Inc · Jun 11, 2026, 11:00 AM
JP Morgan Maintains Overweight on Oculis Holding, Lowers Price Target to $23Benzinga · Jun 3, 2026, 4:30 PM
Oculis Holding shares are trading lower after Baird lowered its price target from $49 to $38.Benzinga · Jun 2, 2026, 3:18 PM
Baird Maintains Outperform on Oculis Holding, Lowers Price Target to $38Benzinga · Jun 2, 2026, 12:22 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock